This report is an updated version of the report published on 23 September 2026 at 12:02 PM AEST.

1.1: Company Overview: OncoSil Medical Limited (ASX: OSL) is a global medical device company specializing in interventional oncology. The company is focused on improving outcomes for patients with cancer through the targeted delivery of Phosphorous-32 (32P) Microparticles directly into tumours alongside chemotherapy. Kalkine’s Healthcare Report covers the Investment Highlights, Management Insights, Key Financial Metrics, Risks, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

Past performance is not a reliable indicator of future performance.